Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Mantle Cell Lymphoma
NCT00005074Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jan 2000
- Primary completion
- Feb 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in mantle cell lymphoma (MCL), sponsored by Canadian Cancer Trials Group. Started Jan 2000; status: completed.
02
Drugs
alvocidib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00005074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005074.